Trials / Completed
CompletedNCT00630019
Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- Sponsor
- Santen Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Compare ocular tissue levels following topical ocular instillation of 1.5% levofloxacin ophthalmic solution or an active comparator in subjects undergoing cataract surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 1.5% levofloxacin ophthalmic solution | Topical application |
| DRUG | 0.5% moxifloxacin hydrochloride ophthalmic solution | Topical application |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2008-10-01
- First posted
- 2008-03-06
- Last updated
- 2009-02-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00630019. Inclusion in this directory is not an endorsement.